Novel molecular approaches to anti-inflammatory therapy /
Saved in:
| Imprint: | Basel ; Boston : Birkhäuser Verlag, c1995. |
|---|---|
| Description: | 178 p. : ill. ; 24 cm. |
| Language: | English |
| Series: | Agents and actions supplements ; vol. 46 Agents and actions supplements ; AAS 46. |
| Subject: | |
| Format: | Print Book |
| URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/2464790 |
MARC
| LEADER | 00000cam a2200000 a 4500 | ||
|---|---|---|---|
| 001 | 2464790 | ||
| 005 | 20040413153500.0 | ||
| 008 | 960531s1995 sz a b 000 0 eng c | ||
| 003 | ICU | ||
| 010 | |a 95001382 | ||
| 020 | |a 3764350962 (Basel : acid-free paper) | ||
| 020 | |a 0817650962 (Boston : acid-free paper) | ||
| 035 | |a (ICU)BID21961500 | ||
| 035 | |a (OCoLC)31936894 | ||
| 040 | |a DNLM/DLC |c DLC |d DLC |d OrLoB-B |d OCoLC | ||
| 041 | 0 | |a eng | |
| 050 | 0 | 0 | |a RM405 |b .N68 1995 |
| 060 | 0 | |a W1 AG33A v.46 1995 |a QV 247 N937 1995 | |
| 082 | 0 | 0 | |a 615/.7 |2 20 |
| 245 | 0 | 0 | |a Novel molecular approaches to anti-inflammatory therapy / |c edited by W. Pruzanski, P. Vadas. |
| 260 | |a Basel ; |a Boston : |b Birkhäuser Verlag, |c c1995. | ||
| 300 | |a 178 p. : |b ill. ; |c 24 cm. | ||
| 336 | |a text |b txt |2 rdacontent |0 http://id.loc.gov/vocabulary/contentTypes/txt | ||
| 337 | |a unmediated |b n |2 rdamedia |0 http://id.loc.gov/vocabulary/mediaTypes/n | ||
| 338 | |a volume |b nc |2 rdacarrier |0 http://id.loc.gov/vocabulary/carriers/nc | ||
| 490 | 1 | |a Agents and actions supplements ; |v vol. 46 | |
| 504 | |a Includes bibliographical references. | ||
| 505 | 0 | 0 | |t Eosinophil chemoattractants generated in vivo / |r T. J. Williams, D. A. Griffiths-Johnson, P. J. Jose and P. D. Collins -- |t Chemokines and their roles in human disease / |r S. L. Kunkel, N. Lukacs and R. M. Strieter -- |t Structure/function analysis of human interleukin 5 and its receptor / |r J. Tavernier, S. Cornelis, R. Devos, Y. Guisez, G. Plaetinck and J. Van der Heyden -- |t Potential phospholipase A[subscript 2]s involved in inflammatory diseases / |r E. A. Dennis -- |t Mediation of inflammation by cyclooxygenase-2 / |r K. Seibert, J. Masferrer, Y. Zhang, S. Gregory, G. Olson, S. Hauser, K. Leahy, W. Perkins and P. Isakson -- |t Secretory phospholipase A[subscript 2] inhibitors. Possible new anti-inflammatory agents / |r K. Tanaka and H. Arita -- |t Recent insights into the structure, function and biology of cPLA[subscript 2] / |r R. Kramer and J. D. Sharp -- |t Control of inflammatory processes by cell-impermeable inhibitors of phospholipase A[subscript 2] / |r S. Yedgar, P. Dan, A. Dagan, I. Ginsburg, I. S. Lossos and R. Breuer -- |t Leukocyte adhesion and the anti-inflammatory effects of leukocyte integrin blockade / |r T. B. Issekutz -- |t ANTI-ICAM in inflammatory disease / |r R. Rothlein -- |t Complementary peptides as recognition molecules / |r G. Fassina -- |t Nitric oxide-releasing NSAIDs: A novel class of GI-sparing anti-inflammatory drugs / |r J. L. Wallace, Q. J. Pittman and G. Cirino -- |t Anti-inflammatory lipocortin-derived peptides / |r M. Perretti and R. J. Flower -- |t Inhibition of lipid mediator biosynthesis in human inflammatory cells by BIRM 270 / |r T. P. Parks, A. F. Hoffman, C. A. Homon, A. G. Graham, E. S. Lazer, E. H. Chilton, P. Borgeat, D. Raible, E. Schulman, D. A. Bass and P. R. Farina -- |t The use of anti-PLCAM reagents control of inflammation / |r W. A. Muller -- |t Selective inhibitors of COX-2 / |r G. P. O'Neill, B. P. Kennedy, J. A. Mancini, S. Kargman, M. Ouellet, J. Yergey, J.-P. Falgueyret, W. A. Cromlish, P. Payette, C.-C. Chan, S. A. Culp, C. Vincent, C. Boily, M. Ambramovitz, J. F. Evans, A. W. Ford-Hutchinson, P. J. Vickers and M. D. Percival -- |t New frontiers in the pharmacotherapy of inflammation / |r R. J. Flower. |
| 650 | 0 | |a Anti-inflammatory agents. |0 http://id.loc.gov/authorities/subjects/sh85005615 | |
| 650 | 1 | 2 | |a Anti-Inflammatory Agents |x pharmacology. |
| 650 | 2 | 2 | |a Inflammation |x drug therapy. |
| 650 | 7 | |a Anti-inflammatory agents. |2 fast |0 http://id.worldcat.org/fast/fst00810354 | |
| 700 | 1 | |a Pruzanski, W. |q (Waldemar) |0 http://id.loc.gov/authorities/names/n84025485 |1 http://viaf.org/viaf/47473166 | |
| 700 | 1 | |a Vadas, P. |q (Peter), |d 1953- |0 http://id.loc.gov/authorities/names/n95800316 |1 http://viaf.org/viaf/78036303 | |
| 830 | 0 | |a Agents and actions supplements ; |v AAS 46. | |
| 901 | |a ToCBNA |a Analytic | ||
| 903 | |a HeVa | ||
| 903 | |a Hathi | ||
| 929 | |a cat | ||
| 999 | f | f | |i 7682ef5c-5a1b-5966-b377-0ed856d91c33 |s 3b8203cd-d416-59f2-a7d1-925dea53f9ed |
| 928 | |t Library of Congress classification |a RM1.A32 v.46 |l ASR |c ASR-SciASR |i 3291566 | ||
| 927 | |t Library of Congress classification |a RM1.A32 v.46 |l ASR |c ASR-SciASR |g Analytic |e CRERAR |b H2464790 |i 4631345 | ||
